JANX
JANX clinical trials: Janux Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Janux Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
JANX on the catalyst calendar · JANX registry changes
- Primary completion Jul 2027Sponsor estimatePhase 1NCT05519449Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Janux Therapeutics · Prostate CancerRecruitingJANXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2029Sponsor estimatePhase 1NCT07813637Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPCJanux Therapeutics · Prostate CancerRecruitingJANXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2028Sponsor estimatePhase 1NCT07545811Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate CancerJanux Therapeutics · Prostate CancerRecruitingJANXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2026Sponsor estimatePhase 1NCT05783622Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesJanux Therapeutics · Non-Small Cell Lung CancerActive, not recruitingJANXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimateEarly Phase 1NCT07291323Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.Janux Therapeutics · AutoimmuneRecruitingJANXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner